Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). Ustekinumab IV Induction Results in Crohn's Disease Symptom Improvement Within the First Week in Anti‐TNF Refractory Patients. American journal of gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sandborn, W. et al. (n.d.). Ustekinumab IV Induction Results in Crohn's Disease Symptom Improvement Within the First Week in Anti‐TNF Refractory Patients. American journal of gastroenterology. p. . [Online].